Evidence map›Paper›PMID 31869524›Full record

ArticleCurrent protocols in molecular biology2020

Use of the CRISPR-Cas9 System in Drosophila Cultured Cells to Introduce Fluorescent Tags into Endogenous Genes.

Justin A Bosch, Shannon Knight, Oguz Kanca, Jonathan Zirin, Donghui Yang-Zhou, Yanhui Hu, Jonathan Rodiger, Gabriel Amador, Hugo J Bellen, Norbert Perrimon and 1 more

Open access · greenAbstract read
In one paragraph

Article in Current protocols in molecular biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Generating CRISPR-edited clonal lines of culturedBiology methods & protocols · 2024
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Justin A BoschDepartment of Genetics, Harvard Medical School, Boston, Massachusetts.
Shannon KnightDepartment of Genetics, Harvard Medical School, Boston, Massachusetts.
Oguz KancaDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas.
Jonathan ZirinDepartment of Genetics, Harvard Medical School, Boston, Massachusetts.
Donghui Yang-ZhouDepartment of Genetics, Harvard Medical School, Boston, Massachusetts.
Yanhui HuDepartment of Genetics, Harvard Medical School, Boston, Massachusetts.
Jonathan RodigerDepartment of Genetics, Harvard Medical School, Boston, Massachusetts.
Gabriel AmadorDepartment of Genetics, Harvard Medical School, Boston, Massachusetts.
Hugo J BellenDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas.
Norbert PerrimonDepartment of Genetics, Harvard Medical School, Boston, Massachusetts.
Stephanie E MohrDepartment of Genetics, Harvard Medical School, Boston, Massachusetts.
Harvard University · USBaylor College of Medicine · US

Funding

VectorP30CA006516 · NCI · DANA-FARBER CANCER INSTITUTE · PI JENNIFER W MACK · 1985 to 2026
$330.6M
Transposon induced disruption of most Drosophila genesR01GM067858 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI BELLEN, HUGO J · 2003 to 2020
$15.7M
New collections of dsRNAs and overexpression miRNA constructs to supplement RNAiR01GM067761 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI PERRIMON, NORBERT · 2003 to 2019
$15.5M
Functional genomics resources for the Drosophila - TR&D3P41GM132087 · NIGMS · HARVARD MEDICAL SCHOOL · PI PERRIMON, NORBERT · 2019 to 2023
$6.8M
Next-generation Drosophila cell lines to elucidate the cellular basis of human diseasesR24OD019847 · OD · HARVARD MEDICAL SCHOOL · PI PERRIMON, NORBERT, SIMCOX, AMANDA · 2017 to 2020
$2.7M
Howard Hughes Medical InstituteNCI NIH HHS P30 CA006516NIGMS NIH HHS P41 GM132087NIGMS NIH HHS R01 GM067761NIGMS NIH HHS R01 GM067858NIH HHS R24 OD019847
6 · The paper itself

Abstract

The CRISPR-Cas9 system makes it possible to cause double-strand breaks in specific regions, inducing repair. In the presence of a donor construct, repair can involve insertion or 'knock-in' of an exogenous cassette. One common application of knock-in technology is to generate cell lines expressing fluorescently tagged endogenous proteins. The standard approach relies on production of a donor plasmid with ∼500 to 1000 bp of homology on either side of an insertion cassette that contains the fluorescent protein open reading frame (ORF). We present two alternative methods for knock-in of fluorescent protein ORFs into Cas9-expressing Drosophila S2R+ cultured cells, the single-stranded DNA (ssDNA) Drop-In method and the CRISPaint universal donor method. Both methods eliminate the need to clone a large plasmid donor for each target. We discuss the advantages and limitations of the standard, ssDNA Drop-In, and CRISPaint methods for fluorescent protein tagging in Drosophila cultured cells. © 2019 by John Wiley & Sons, Inc. Basic Protocol 1: Knock-in into Cas9-positive S2R+ cells using the ssDNA Drop-In approach Basic Protocol 2: Knock-in into Cas9-positive S2R+ cells by homology-independent insertion of universal donor plasmids that provide mNeonGreen (CRISPaint method) Support Protocol 1: sgRNA design and cloning Support Protocol 2: ssDNA donor synthesis Support Protocol 3: Transfection using Effectene Support Protocol 4: Electroporation of S2R+-MT::Cas9 Drosophila cells Support Protocol 5: Single-cell isolation of fluorescent cells using FACS.

Indexed as

CRISPR-Cas SystemsGenes, InsectOpen Reading FramesAnimalsCells, CulturedClustered Regularly Interspaced Short Palindromic RepeatsDNA, Single-StrandedDrosophilaGene EditingGene Knock-In TechniquesGreen Fluorescent ProteinsPlasmidsRNA, Guide, CRISPR-Cas SystemsTransfectionDNA, Single-StrandedGreen Fluorescent ProteinsRNA, Guide, CRISPR-Cas Systemscell cultureCRISPaintCRISPRDrosophilafluorescent protein tagginggene taggingGFP fusionknock-inssDNA Drop-In

Identifiers

PMID31869524
PMCPMC7213786
OpenAlexW2997166190

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.